AIM:AMS

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Advanced Medical Solutions Group

Executive Summary

Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, Europe, the United States, and internationally.

Rewards

PE ratio (25x) is below the Medical Equipment industry average (26.7x)

Earnings are forecast to grow 3.03% per year

Risk Analysis

No risks detected for AMS from our risk checks.


Snowflake Analysis

Excellent balance sheet and slightly overvalued.

Share Price & News

How has Advanced Medical Solutions Group's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: AMS has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

-10.0%

AMS

5.9%

GB Medical Equipment

1.6%

GB Market


1 Year Return

-24.0%

AMS

0.9%

GB Medical Equipment

-14.0%

GB Market

Return vs Industry: AMS underperformed the UK Medical Equipment industry which returned -3.9% over the past year.

Return vs Market: AMS underperformed the UK Market which returned -15.7% over the past year.


Shareholder returns

AMSIndustryMarket
7 Day-10.0%5.9%1.6%
30 Day-9.7%1.0%2.9%
90 Day-3.5%9.7%12.3%
1 Year-23.5%-24.0%2.9%0.9%-10.0%-14.0%
3 Year-22.9%-24.0%11.0%4.5%-3.2%-15.2%
5 Year49.0%45.8%57.4%43.8%16.9%-9.3%

Price Volatility Vs. Market

How volatile is Advanced Medical Solutions Group's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Advanced Medical Solutions Group undervalued compared to its fair value and its price relative to the market?

25.03x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: AMS (£2.21) is trading above our estimate of fair value (£2.12)

Significantly Below Fair Value: AMS is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: AMS is good value based on its PE Ratio (25x) compared to the GB Medical Equipment industry average (26.7x).

PE vs Market: AMS is poor value based on its PE Ratio (25x) compared to the UK market (15.3x).


Price to Earnings Growth Ratio

PEG Ratio: AMS is poor value based on its PEG Ratio (8.3x)


Price to Book Ratio

PB vs Industry: AMS is good value based on its PB Ratio (2.5x) compared to the GB Medical Equipment industry average (2.8x).


Next Steps

Future Growth

How is Advanced Medical Solutions Group forecast to perform in the next 1 to 3 years based on estimates from 7 analysts?

3.0%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: AMS's forecast earnings growth (3% per year) is above the savings rate (1.2%).

Earnings vs Market: AMS's earnings (3% per year) are forecast to grow slower than the UK market (21.7% per year).

High Growth Earnings: AMS's earnings are forecast to grow, but not significantly.

Revenue vs Market: AMS's revenue (5.8% per year) is forecast to grow faster than the UK market (3.3% per year).

High Growth Revenue: AMS's revenue (5.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: AMS's Return on Equity is forecast to be low in 3 years time (10.3%).


Next Steps

Past Performance

How has Advanced Medical Solutions Group performed over the past 5 years?

11.1%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: AMS has high quality earnings.

Growing Profit Margin: AMS's current net profit margins (18.5%) are lower than last year (21.9%).


Past Earnings Growth Analysis

Earnings Trend: AMS's earnings have grown by 11.1% per year over the past 5 years.

Accelerating Growth: AMS's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: AMS had negative earnings growth (-15.9%) over the past year, making it difficult to compare to the Medical Equipment industry average (-9.5%).


Return on Equity

High ROE: AMS's Return on Equity (9.9%) is considered low.


Next Steps

Financial Health

How is Advanced Medical Solutions Group's financial position?


Financial Position Analysis

Short Term Liabilities: AMS's short term assets (£111.8M) exceed its short term liabilities (£17.2M).

Long Term Liabilities: AMS's short term assets (£111.8M) exceed its long term liabilities (£18.6M).


Debt to Equity History and Analysis

Debt Level: AMS's debt to equity ratio (0.3%) is considered satisfactory.

Reducing Debt: AMS's debt to equity ratio has increased from 0% to 0.3% over the past 5 years.

Debt Coverage: AMS's debt is well covered by operating cash flow (3267.9%).

Interest Coverage: AMS's interest payments on its debt are well covered by EBIT (76.4x coverage).


Balance Sheet


Next Steps

Dividend

What is Advanced Medical Solutions Group current dividend yield, its reliability and sustainability?

0.70%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: AMS's dividend (0.7%) isn’t notable compared to the bottom 25% of dividend payers in the UK market (1.92%).

High Dividend: AMS's dividend (0.7%) is low compared to the top 25% of dividend payers in the UK market (5.41%).


Stability and Growth of Payments

Stable Dividend: AMS is not paying a notable dividend for the UK market, therefore no need to check if payments are stable.

Growing Dividend: AMS is not paying a notable dividend for the UK market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: AMS is not paying a notable dividend for the UK market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of AMS's dividend in 3 years as they are not forecast to pay a notable one for the UK market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.4yrs

Average management tenure


CEO

Chris Meredith (53yo)

9.5yrs

Tenure

UK£770,000

Compensation

Mr. Andrew Christopher Meredith, also known as Chris, B.Sc. (Hons.) has been the Chief Executive Officer of Advanced Medical Solutions Group plc since January 2011 and served as Chief Operating Officer sin ...


CEO Compensation Analysis

Compensation vs Market: Chris's total compensation ($USD971.16K) is about average for companies of similar size in the UK market ($USD915.66K).

Compensation vs Earnings: Chris's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Andrew Meredith
CEO & Executive Director9.5yrsUK£770.00k0.70% £3.3m
Edward Johnson
CFO, Company Secretary & Director1.5yrsUK£338.00k0.032% £149.9k
Alan Richardson
Chief Operations Officer1.67yrsno datano data
Cathy Tomlinson
Group Human Resources Director3.17yrsno datano data
Brian Dowd
Head of US Commercial Teamno datano datano data

2.4yrs

Average Tenure

Experienced Management: AMS's management team is considered experienced (2.4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Andrew Meredith
CEO & Executive Director9.5yrsUK£770.00k0.70% £3.3m
Edward Johnson
CFO, Company Secretary & Director1.5yrsUK£338.00k0.032% £149.9k
Penelope Freer
Senior Independent Non-Executive Director10.33yrsUK£44.00k0.0074% £35.3k
Stephen Bellamy
Independent Non-Executive Director13.42yrsUK£44.00k0.046% £220.5k
Peter Allen
Independent Non-Executive Chairman6.5yrsUK£74.00k0.023% £110.3k

10.3yrs

Average Tenure

59yo

Average Age

Experienced Board: AMS's board of directors are seasoned and experienced ( 10.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Advanced Medical Solutions Group plc's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Advanced Medical Solutions Group plc
  • Ticker: AMS
  • Exchange: AIM
  • Founded: 1991
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Market Cap: UK£474.484m
  • Shares outstanding: 215.19m
  • Website: https://www.admedsol.com

Number of Employees


Location

  • Advanced Medical Solutions Group plc
  • Premier Park
  • 33 Road One
  • Winsford
  • Cheshire
  • CW7 3RT
  • United Kingdom

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
AQADB (Deutsche Boerse AG)YesOrdinary SharesDEEURDec 1994
AMSAIM (London Stock Exchange AIM Market)YesOrdinary SharesGBGBPDec 1994

Biography

Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare. The Surgical segment offers topical tissue adhesives for wound closure and sealing under the LiquiBand; sutures and collagen based products for the surgical and dental markets under the RESORBA; collagens; and laparoscopic device which reduces surgical complications under the LiquiBand Fix8 brands. The Woundcare segment provides wound care platform technologies, which include alginates, foams, films, fibres, hydrogels, antimicrobial dressings, and hydrocolloids, as well as wound care products under the ActivHeal. It also sells its products under the Seal-G and Biomatlante brand names, such as Moldable Bone Graft Substitute, a biphasic calcium phosphate synthetic bone graft substitute that includes Syringes, Inserts, and In’Oss; EZ Cure, a collagen membranes; and Osteotwin, a Biocompatible Interference Resorbable Screw. The company was founded in 1991 and is headquartered in Winsford, the United Kingdom. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/07/15 20:53
End of Day Share Price2020/07/15 00:00
Earnings2019/12/31
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.